ZA966969B - Medicaments - Google Patents

Medicaments

Info

Publication number: ZA966969B
Authority: ZA; South Africa
Prior art keywords: medicaments
Prior art date: 1995-08-19

Application number

ZA966969A

Inventor

Hugh Brownlie Mcdade

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-19

Filing date

1996-08-16

Publication date

1997-03-24

1996-08-16 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1997-03-24 Publication of ZA966969B publication Critical patent/ZA966969B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA966969A 1995-08-19 1996-08-16 Medicaments ZA966969B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9517022.1A GB9517022D0 (en)	1995-08-19	1995-08-19	Medicaments

Publications (1)

Publication Number	Publication Date
ZA966969B true ZA966969B (en)	1997-03-24

Family

ID=10779487

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA966969A ZA966969B (en)	1995-08-19	1996-08-16	Medicaments

Country Status (6)

Country	Link
EP (1)	EP0844878A1 (en)
JP (1)	JPH11512083A (en)
AU (1)	AU6924796A (en)
GB (1)	GB9517022D0 (en)
WO (1)	WO1997006804A1 (en)
ZA (1)	ZA966969B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9605293D0 (en) *	1996-03-13	1996-05-15	Glaxo Group Ltd	Medicaments
US6767991B1 (en)	1997-08-11	2004-07-27	Boehringer Ingelheim (Canada) Ltd.	Hepatitis C inhibitor peptides
HUP0100100A3 (en) *	1997-08-11	2001-12-28	Boehringer Ingelheim Ca Ltd	Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
EA200700564A1 (en) *	1998-02-25	2007-08-31	Эмори Юниверсити	2`-Fluoride
US6323180B1 (en)	1998-08-10	2001-11-27	Boehringer Ingelheim (Canada) Ltd	Hepatitis C inhibitor tri-peptides
US6608027B1 (en)	1999-04-06	2003-08-19	Boehringer Ingelheim (Canada) Ltd	Macrocyclic peptides active against the hepatitis C virus
GB9909154D0 (en) *	1999-04-22	1999-06-16	Nippon Glaxo Limited	Pharmaceutical formulation
WO2001007027A2 (en) *	1999-07-22	2001-02-01	Vertex Pharmaceuticals Incorporated	Pyrimidine derivatives for the treatment of viral diseases
JP4452441B2 (en)	2000-07-21	2010-04-21	シェーリングコーポレイション	Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
US7244721B2 (en)	2000-07-21	2007-07-17	Schering Corporation	Peptides as NS3-serine protease inhibitors of hepatitis C virus
DE60141608D1 (en)	2000-07-21	2010-04-29	Dendreon Corp	PEPTIDES AS INHIBITORS OF THE NS3 SERINE PROTEASE OF HEPATITIS C VIRUS
KR20090089922A (en) *	2000-10-18	2009-08-24	파마셋 인코포레이티드	Modified nucleosides for the treatment of viral infections and abnormal cell proliferation
JP4312718B2 (en)	2002-05-20	2009-08-12	ブリストル−マイヤーズスクイブカンパニー	Hepatitis C virus inhibitor
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
DE60334205D1 (en)	2002-05-20	2010-10-28	Bristol Myers Squibb Co	Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
PL213029B1 (en)	2002-05-20	2012-12-31	Bristol Myers Squibb Co	Substituted cycloalkyl p1' hepatitis c virus inhibitors
WO2004103996A1 (en)	2003-05-21	2004-12-02	Boehringer Ingelheim International Gmbh	Hepatitis c inhibitor compounds
US20050058044A1 (en) *	2003-09-12	2005-03-17	Koegler John M.	Optical disk modified for speed and orientation tracking
MXPA06003141A (en)	2003-09-22	2006-06-05	Boehringer Ingelheim Int	Macrocyclic peptides active against the hepatitis c virus.
KR100853579B1 (en)	2003-10-14	2008-08-21	인터뮨, 인크.	Macrocyclic Carboxylic Acids and Acylsulfonamides as HCl Replication Inhibitors
US7132504B2 (en)	2003-11-12	2006-11-07	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7309708B2 (en)	2003-11-20	2007-12-18	Birstol-Myers Squibb Company	Hepatitis C virus inhibitors
US7135462B2 (en)	2003-11-20	2006-11-14	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
WO2005070955A1 (en)	2004-01-21	2005-08-04	Boehringer Ingelheim International Gmbh	Macrocyclic peptides active against the hepatitis c virus
UY29016A1 (en)	2004-07-20	2006-02-24	Boehringer Ingelheim Int	ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
JP4914355B2 (en)	2004-07-20	2012-04-11	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Hepatitis C inhibitor peptide analog
MX2008001166A (en)	2005-07-25	2008-03-18	Intermune Inc	Novel macrocyclic inhibitors of hepatitis c virus replication.
US8119592B2 (en)	2005-10-11	2012-02-21	Intermune, Inc.	Compounds and methods for inhibiting hepatitis C viral replication
CN101511375B (en) *	2005-12-02	2012-09-05	耶鲁大学	Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs
EA200971074A1 (en)	2007-06-29	2010-08-30	Джилид Сайэнс, Инк.	ANTI-VIRUS CONNECTIONS
KR101596524B1 (en)	2007-06-29	2016-02-22	길리애드 사이언시즈, 인코포레이티드	Antiviral compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL100502A (en) *	1991-01-03	1995-12-08	Iaf Biochem Int	Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives

1995
- 1995-08-19 GB GBGB9517022.1A patent/GB9517022D0/en active Pending
1996
- 1996-08-16 JP JP9508948A patent/JPH11512083A/en active Pending
- 1996-08-16 ZA ZA966969A patent/ZA966969B/en unknown
- 1996-08-16 WO PCT/EP1996/003601 patent/WO1997006804A1/en not_active Application Discontinuation
- 1996-08-16 AU AU69247/96A patent/AU6924796A/en not_active Abandoned
- 1996-08-16 EP EP96930043A patent/EP0844878A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
JPH11512083A (en)	1999-10-19
GB9517022D0 (en)	1995-10-25
WO1997006804A1 (en)	1997-02-27
EP0844878A1 (en)	1998-06-03
AU6924796A (en)	1997-03-12

Publication	Publication Date	Title
HUP9801151A3 (en)	2000-06-28	Long-shelf-life medicaments
GB9517022D0 (en)	1995-10-25	Medicaments
AP9700951A0 (en)	1997-04-30	Medicaments
GB9406573D0 (en)	1994-05-25	Medicaments
GB9420784D0 (en)	1994-11-30	Medicaments
GB9526392D0 (en)	1996-02-21	Medicaments
GB9503850D0 (en)	1995-04-19	Medicaments
GB9418530D0 (en)	1994-11-02	Medicaments
GB9411052D0 (en)	1994-07-20	Medicaments
GB9421133D0 (en)	1994-12-07	Medicaments
GB9416365D0 (en)	1994-10-05	Medicaments
IL127776A0 (en)	1999-10-28	Medicaments
GB9524173D0 (en)	1996-01-24	Medicaments
GB9506122D0 (en)	1995-05-10	Medicaments
GB9523453D0 (en)	1996-01-17	Medicaments
GB9504153D0 (en)	1995-04-19	Medicaments
GB9521208D0 (en)	1995-12-20	Medicaments
GB9514723D0 (en)	1995-09-20	Medicaments
GB9519029D0 (en)	1995-11-15	Medicaments
GB9515628D0 (en)	1995-09-27	Medicaments
GB9519585D0 (en)	1995-11-29	Medicaments
GB9519021D0 (en)	1995-11-15	Medicaments
GB9517021D0 (en)	1995-10-25	Medicaments
GB9424013D0 (en)	1995-01-18	Medicaments
EP0790829A4 (en)	2001-08-08	Medicaments